Eliem Therapeutics, Inc. Annual Share-based Payment Arrangement, Expense in USD from 2020 to 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
Summary
Eliem Therapeutics, Inc. quarterly/annual Share-based Payment Arrangement, Expense history and growth rate from 2020 to 2023.
  • Eliem Therapeutics, Inc. Share-based Payment Arrangement, Expense for the quarter ending June 30, 2024 was $512K, a 34.1% decline year-over-year.
  • Eliem Therapeutics, Inc. Share-based Payment Arrangement, Expense for the twelve months ending June 30, 2024 was $2.84M, a 80.6% decline year-over-year.
  • Eliem Therapeutics, Inc. annual Share-based Payment Arrangement, Expense for 2023 was $12.8M, a 83.2% increase from 2022.
  • Eliem Therapeutics, Inc. annual Share-based Payment Arrangement, Expense for 2022 was $6.99M, a 87.1% increase from 2021.
  • Eliem Therapeutics, Inc. annual Share-based Payment Arrangement, Expense for 2021 was $3.74M, a 429% increase from 2020.
Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)
Share-based Payment Arrangement, Expense, Annual (USD)
Share-based Payment Arrangement, Expense, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 $12.8M +$5.82M +83.2% Jan 1, 2023 Dec 31, 2023 10-K 2024-03-28
2022 $6.99M +$3.25M +87.1% Jan 1, 2022 Dec 31, 2022 10-K 2024-03-28
2021 $3.74M +$3.03M +429% Jan 1, 2021 Dec 31, 2021 10-K 2023-03-06
2020 $707K Jan 1, 2020 Dec 31, 2020 10-K 2022-03-07
* An asterisk sign (*) next to the value indicates that the value is likely invalid.